Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023132664> ?p ?o ?g. }
- W2023132664 endingPage "5492" @default.
- W2023132664 startingPage "5482" @default.
- W2023132664 abstract "Gefitinib (GFT) and other tyrosine kinase inhibitors (TKIs) have been widely used for the treatment of advanced or metastatic lung cancer due to their reduced side effects when compared to classic cytotoxic chemotherapeutic agents. However, both intrinsic and acquired resistance often hinders the effectiveness of TKIs. Based on recent findings that the outcome of chemotherapy can be influenced by the host immune system at multiple levels, an exploration of whether activating antitumor immunity improves the efficacy of the targeted cancer therapy of TKIs is undertaken. To this end, a cationic carrier is used to deliver superantigen and GFT in a simultaneous or sequential manner. The sequential delivery of superantigen and GFT can significantly enhance T cell immunity, promote cytokine production, inhibit tumor growth, and prolong survival time in tumor models with lung carcinoma xenografts. Most importantly, dual sequential treatment reveals a synergistic effect on tumor inhibition, which is much more effective than the monotherapy of either GFT or pTSA, as well as the combined treatment through simultaneous codelivery of pTSA and GFT together. This study demonstrates the important contribution of immunotherapy to targeted molecular therapy and opens up new possibilities for treating a wide spectrum of cancers." @default.
- W2023132664 created "2016-06-24" @default.
- W2023132664 creator A5003631736 @default.
- W2023132664 creator A5018202477 @default.
- W2023132664 creator A5022173400 @default.
- W2023132664 creator A5036149545 @default.
- W2023132664 creator A5041131193 @default.
- W2023132664 creator A5061757825 @default.
- W2023132664 date "2014-06-20" @default.
- W2023132664 modified "2023-10-18" @default.
- W2023132664 title "Synergistic Enhancement of Lung Cancer Therapy Through Nanocarrier-Mediated Sequential Delivery of Superantigen and Tyrosin Kinase Inhibitor" @default.
- W2023132664 cites W1974758811 @default.
- W2023132664 cites W1978932462 @default.
- W2023132664 cites W1979379635 @default.
- W2023132664 cites W1984206354 @default.
- W2023132664 cites W1984301004 @default.
- W2023132664 cites W1985428686 @default.
- W2023132664 cites W1995437728 @default.
- W2023132664 cites W1995853527 @default.
- W2023132664 cites W2001305340 @default.
- W2023132664 cites W2003104864 @default.
- W2023132664 cites W2003984225 @default.
- W2023132664 cites W2008171455 @default.
- W2023132664 cites W2013525973 @default.
- W2023132664 cites W2013800359 @default.
- W2023132664 cites W2023980114 @default.
- W2023132664 cites W2031583328 @default.
- W2023132664 cites W2035837062 @default.
- W2023132664 cites W2044609602 @default.
- W2023132664 cites W2045118139 @default.
- W2023132664 cites W2048657818 @default.
- W2023132664 cites W2052874737 @default.
- W2023132664 cites W2057123987 @default.
- W2023132664 cites W2058743530 @default.
- W2023132664 cites W2058962254 @default.
- W2023132664 cites W2066223920 @default.
- W2023132664 cites W2070878738 @default.
- W2023132664 cites W2071622021 @default.
- W2023132664 cites W2076717138 @default.
- W2023132664 cites W2081340395 @default.
- W2023132664 cites W2083435341 @default.
- W2023132664 cites W2083570617 @default.
- W2023132664 cites W2091083398 @default.
- W2023132664 cites W2094531406 @default.
- W2023132664 cites W2106631163 @default.
- W2023132664 cites W2108165319 @default.
- W2023132664 cites W2121389354 @default.
- W2023132664 cites W2143611932 @default.
- W2023132664 cites W2157058802 @default.
- W2023132664 cites W2169816570 @default.
- W2023132664 cites W2281508338 @default.
- W2023132664 cites W2335409573 @default.
- W2023132664 cites W4234236664 @default.
- W2023132664 cites W4323873860 @default.
- W2023132664 doi "https://doi.org/10.1002/adfm.201400456" @default.
- W2023132664 hasPublicationYear "2014" @default.
- W2023132664 type Work @default.
- W2023132664 sameAs 2023132664 @default.
- W2023132664 citedByCount "17" @default.
- W2023132664 countsByYear W20231326642015 @default.
- W2023132664 countsByYear W20231326642016 @default.
- W2023132664 countsByYear W20231326642017 @default.
- W2023132664 countsByYear W20231326642018 @default.
- W2023132664 countsByYear W20231326642019 @default.
- W2023132664 countsByYear W20231326642020 @default.
- W2023132664 countsByYear W20231326642021 @default.
- W2023132664 countsByYear W20231326642022 @default.
- W2023132664 crossrefType "journal-article" @default.
- W2023132664 hasAuthorship W2023132664A5003631736 @default.
- W2023132664 hasAuthorship W2023132664A5018202477 @default.
- W2023132664 hasAuthorship W2023132664A5022173400 @default.
- W2023132664 hasAuthorship W2023132664A5036149545 @default.
- W2023132664 hasAuthorship W2023132664A5041131193 @default.
- W2023132664 hasAuthorship W2023132664A5061757825 @default.
- W2023132664 hasConcept C121608353 @default.
- W2023132664 hasConcept C126322002 @default.
- W2023132664 hasConcept C143998085 @default.
- W2023132664 hasConcept C18150654 @default.
- W2023132664 hasConcept C203014093 @default.
- W2023132664 hasConcept C2776090121 @default.
- W2023132664 hasConcept C2776256026 @default.
- W2023132664 hasConcept C2776999253 @default.
- W2023132664 hasConcept C2777701055 @default.
- W2023132664 hasConcept C2779438470 @default.
- W2023132664 hasConcept C2780035454 @default.
- W2023132664 hasConcept C2780580887 @default.
- W2023132664 hasConcept C2781230642 @default.
- W2023132664 hasConcept C36333154 @default.
- W2023132664 hasConcept C502942594 @default.
- W2023132664 hasConcept C71924100 @default.
- W2023132664 hasConcept C8891405 @default.
- W2023132664 hasConcept C98274493 @default.
- W2023132664 hasConceptScore W2023132664C121608353 @default.
- W2023132664 hasConceptScore W2023132664C126322002 @default.
- W2023132664 hasConceptScore W2023132664C143998085 @default.
- W2023132664 hasConceptScore W2023132664C18150654 @default.
- W2023132664 hasConceptScore W2023132664C203014093 @default.
- W2023132664 hasConceptScore W2023132664C2776090121 @default.